NLS CDMO

The development-stage pharmaceutical company Transpire Bio has announced a definitive agreement with Recipharm to develop TRB-1 and TRB-2, inhaled medicines for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD). TRB-1 and TRB-2, the first products developed by Transpire Bio will be indicated for the treatment of asthma and COPD, intended for advanced markets. […]

Recipharm has announced the acquisition of Arranta Bio, an advanced therapy CDMO, and Vibalogics, a virotherapy CDMO and a portfolio company of Ampersand Capital Partners. The acquisition of Arranta Bio forms a cornerstone of Recipharm’s strategy to provide innovative drug developers in the biologics market with scientifically differentiated contract development and manufacturing services for ATMPs […]

Recipharm has announced the acquisition of GenIbet, a Portuguese CDMO, specializing in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome. The acquisition forms part of Recipharm’s strategy to grow in the biologics market, with a particular focus on drug substance manufacturing of novel ATMPs, the company […]

Recipharm has announced the completion of a new analytical laboratory at its facility in Bengaluru, India. The new 370 m2 area is fully cGMP compliant and is equipped with technology and instruments to cater for the rising demand from customers for the company’s stand-alone Recipharm Analytical Solutions, states the company. “It’s great to be able […]

Recipharm has announced investment into a new facility in Uttarakhand, India which will see its fill finish capacity increase to 1 billion sterile units per year. The facility will be constructed on a greenfield site near Dehradun in Uttarakhand and is a joint project between Recipharm and the Sobti family. Read more: Recipharm launches new […]

Recipharm, has signed an Memorandum of Understanding (MOU) for the fill finish of vaccines and biotherapeutics in Morocco. Recipharm has signed the MOU, along with His Majesty the King of Morocco, the Moroccan government and a consortium of the country’s leading banks, that will see the company operate a new fill finish factory in Morocco. […]